Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Comprehensive insulin signalling map shows interplay between genes and diet September 25, 2023 Greater PTSD symptoms lead to worse sexual functioning among midlife women September 27, 2023 Neurofunctional architecture and intention understanding in preschool children July 16, 2024